Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)

Detalles Bibliográficos
Autores principales: Tepper, Stewart J., Ailani, Jessica, Ford, Janet H., Nichols, Russell M., Li, Lily Q., Kemmer, Phebe, Hand, Austin L., Tockhorn-Heidenreich, Antje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930929/
https://www.ncbi.nlm.nih.gov/pubmed/35254628
http://dx.doi.org/10.1007/s40261-022-01123-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930929/
https://www.ncbi.nlm.nih.gov/pubmed/35254628
http://dx.doi.org/10.1007/s40261-022-01123-z

Ejemplares similares